Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Calidi Biotherapeutics, Inc. (CLDI) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Calidi Biotherapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1855485.
Total stock buying since 2022: $455,000.
Total stock sales since 2022: $374,580.
Total stock option exercises since 2022: $109,600.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 227,500 | $455,000 | 0 | $0 | 0 | $0 |
| 2024 | 0 | $0 | 10,000 | $16,200 | 548,000 | $109,600 |
| 2022 | 0 | $0 | 36,200 | $358,380 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 227,500 | $455,000 | 0 | $0 | 0 | $0 |
| 2024-12 | 0 | $0 | 10,000 | $16,200 | 0 | $0 |
| 2024-06 | 0 | $0 | 0 | $0 | 548,000 | $109,600 |
| 2022-10 | 0 | $0 | 36,200 | $358,380 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-21 | Leftwich Scott | Buy | 125,000 | 2.00 | 250,000 |
| 2025-08-21 | Jackson Andrew C. (Chief Financial Officer) | Buy | 2,500 | 2.00 | 5,000 |
| 2025-08-21 | Schoeneck James A | Buy | 75,000 | 2.00 | 150,000 |
| 2025-08-21 | Poma Eric E (Chief Executive Officer) | Buy | 25,000 | 2.00 | 50,000 |
| 2024-12-17 | Camaisa Allan (CEO and Chairman of the Board) | Sale | 10,000 | 1.62 | 16,200 |
| 2024-06-03 | Schoeneck James A | Option Ex | 548,000 | .20 | 109,600 |
| 2022-10-19 | Polar Asset Management Partners Inc. (10% Owner) | Sale | 36,200 | 9.90 | 358,380 |
Insider trading activities including stock purchases, stock sales, and option exercises of CLDI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Calidi Biotherapeutics, Inc. (symbol CLDI, CIK number 1855485) see the Securities and Exchange Commission (SEC) website.